Fierce Health Tirzepatide Review: Cost, a Cleared Warning-Letter Claim & Honest Verdict (2026)

Before anything else, a correction: an earlier version of this review left an unconfirmed FDA warning-letter claim standing against Fierce Health. That claim is withdrawn — there is no FDA warning letter on record for this company, and the section below sets out how that was established.

The warning-letter claim, checked and cleared

On 7 August 2026 FDA's complete warning-letter index was paged in full — all 3,651 rows — and matched offline on the company column, the column FDA itself files a letter under, rather than by fulltext search, which matches letter bodies and whose zeroes prove nothing. Fierce Health does not appear in it, under that name or under "Fierce" alone. In the same pass, SkinnyRx returned its known February 2026 letter and Belle Health returned its own, which is what makes the zero a result rather than a search that quietly failed. To be exact about what this establishes: as of 7 August 2026, FDA's own warning-letter database holds no warning letter on file for this company. It is not a verdict on Fierce Health in any other respect — the trade-offs below are unchanged, and it is the reason the earlier hedged wording has been replaced rather than deleted.

Live verification was also rate-limited

Separately, this review attempted to independently confirm Fierce Health's current pricing and program details directly against fiercehealth.com. The site returned a rate-limit response this check, blocking verification. Every figure below was last verified on July 26, 2026.

What Fierce Health is

Fierce Health is a direct-to-consumer telehealth brand, selling compounded semaglutide and tirzepatide in both standard and microdose programs, alongside a longevity catalog. It's LegitScript certified, publishes the FDA compounded-medication disclaimer on every product page, and spells out its 30-state service area explicitly in the Terms — genuinely checkable, rather than vague "most states" language.

What Fierce Health costs

The tirzepatide weight-loss program runs $497/month on a 3-month plan, though at the time of prior research it was showing "sold out or unavailable" across all plans — worth confirming current availability directly. A microdose tier at $197/month is one of the lower entry points documented on this site.

The brand-vs-compounded question

Fierce Health dispenses compounded tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Fierce Health's real strengths is an explicitly published 30-state service list, LegitScript certification, a published FDA compounded-medication disclaimer on every product page, and a broader four-program GLP-1 ladder (standard and microdose, both molecules) than most peers. The trade-offs are real: no named 503A compounding pharmacy is published, the operating LLC name isn't disclosed, the clinical provider network isn't named, and the tirzepatide program was showing as sold out at last check. This review's own attempt to verify any of it live was also blocked by a rate limit. What is no longer a trade-off is the regulatory claim: no FDA warning letter is on record for this company, checked against FDA's complete index on the company column. As with any GLP-1 program, confirm current availability before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Fierce Health's explicit 30-state list and LegitScript certification are genuine positives and the regulatory claim this site once left hanging over the company is cleared: no such letter exists in FDA's index. What is left is ordinary diligence — the site could not be verified live this check, and the tirzepatide program was listed as sold out at last check, so confirm both before you commit. For two providers that do have a letter on record, and where this review says so plainly, see SkinnyRx or Belle Health. See our best tirzepatide providers ranking for the full field.